Serum ZAG levels in the central obesity group were significantly lower in comparison with the control group (8.37 ± 1.52 μg/mL vs. 8.78 ± 1.66 μg/mL, P < 0.05). The gene discussed is AZGP1; the disease is Abdominal obesity.